Avant Garde/Avenir award for Investigators conducting high risk/high reward research on HIV and Substance Use (or Substance Use Disorders)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute on Drug Abuse (NIDA) plans to issue a Notice of Funding Opportunity (NOFO) for the Avant-Garde Award Program, which seeks groundbreaking research proposals that address major challenges in HIV and substance use or substance use disorders (SUD). The program is aimed at supporting exceptionally creative scientists who propose high-risk, high-reward, and potentially transformative biomedical and behavioral research approaches. Special emphasis is placed on encouraging early-stage investigators to participate. While applications are not currently being accepted, this advance notice is intended to give researchers ample time to form collaborations and develop responsive project proposals. This funding opportunity will utilize the DP1 activity code and is coordinated by the National Institutes of Health under the Department of Health and Human Services. Investigators with expertise in the intersection of substance use and HIV are encouraged to begin preparing for submission when the NOFO becomes active. The point of contact for inquiries about the program is Vasundhara Varthakavi, DVM, Ph.D., at the National Institute on Drug Abuse. Additional details and updates will be accessible through the designated NIH grants website.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institue on Drug Abuse (NIDA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on pioneering research in HIV and Substance use/substance use disorder (SUD) research. The Avant-Garde Award Program is designed to support exceptionally creative scientists who propose cutting edge high risk and high reward and possibly transformative approaches to major challenges in biomedical and behavioral research on HIV in the context of substance use and/or SUDs. This Program includes supporting early stage investigators (ESI). Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the DP1 activity code. Investigators with expertise and insights into this area of substance use and HIV are encouraged to begin to consider applying for this new NOFO.
